Epidemiology and treatment of psoriasis: a Brazilian perspective

References

• LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature2007445713086687317314973
   PubMed Web of Science ®Google Scholar
• FriedewaldVECatherJCGelfandJMAJC editor’s consensus: psoriasis and coronary artery diseaseAm J Cardiol2008102121631164319064017
   PubMed Web of Science ®Google Scholar
• GudjonssonJEElderJTPsoriasis: epidemiologyClin Dermatol200725653554618021890
   PubMed Web of Science ®Google Scholar
• ChristophersEPsoriasis–epidemiology and clinical spectrumClin Exp Dermatol200126431432011422182
   PubMed Web of Science ®Google Scholar
• SchönMPBoehnckeWHBröckerEBPsoriasis: clinical manifestations, pathogenesis and therapeutic perspectivesDiscov Med200552725325820704884
   PubMedGoogle Scholar
• SchaeferIRustenbachSJZimmerLAugustinMPrevalence of skin diseases in a cohort of 48,665 employees in GermanyDermatology2008217216917218525204
   PubMed Web of Science ®Google Scholar
• SilvaLMRocha BdeONobreACRêgoVRFolladorIOliveira MdeFAnti-TNFα therapy in the management of psoriasis: experience of a state referral centerAn Bras Dermatol201489343644024937817
   PubMed Web of Science ®Google Scholar
• CostaSCHirotaSKTakahashiMDAndradeHJMigliariDAOral lesions in 166 patients with cutaneous psoriasis: a controlled studyMed Oral Patol Oral Cir Bucal2009148e371e37519300356
   PubMed Web of Science ®Google Scholar
• PiccianiBLMichalski-SantosBCarneiroSOral candidiasis in patients with psoriasis: correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatmentJ Am Acad Dermatol201368698699123384796
   PubMed Web of Science ®Google Scholar
• OliveiraMFPRochaBOFragaNAOphthalmic manifestations in psoriatic patients in a Brazilian referral centerPoster presented at: 3rd World Psoriasis and Psoriatic Arthritis conference72012Stockholm, Sweden
   Google Scholar
• LimaFBAbalemMFRuizDGPrevalence of eye disease in Brazilian patients with psoriatic arthritisClinics (São Paulo)201267324925322473406
   PubMed Web of Science ®Google Scholar
• Amaral MaiaCPTakahashiMDRomitiRSociedade Brasileira De DermatologiaConsenso Brasileiro de Psoríase 2012 – Guias de Avaliação e Tratamento2a edNew YorkBiblioteca2012978-85-89240-04-8
   Google Scholar
• MrowietzUKragballeKReichKDefinition of treatment goals for moderate to severe psoriasis: a European consensusArch Dermatol Res2011303111020857129
   PubMed Web of Science ®Google Scholar
• PintoMTRodriguesESMaltaTMHTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-upRev Inst Med Trop Sao Paulo201254312312922634882
   PubMed Web of Science ®Google Scholar
• who.int [homepage on the internet]Global tuberculosis control: a short update to the 2009 report2009 Available from: http://www.who.int/tb/publications/global_report/2009/update/en/) websiteAccessed November 25, 2014
   Google Scholar
• Suvisa.ba.gov.br [homepage on the internet]Recomendações para controle de contatos e tratamento da infecção latente da tuberculose na indisponibilidade transitória do Derivado Proteico Purificado2014 Available from: http://www.suvisa.ba.gov.br/sites/default/files/vigilancia_epidemiologica/doencas_transmissiveis/arquivo/2014/10/15/Nota%20Informativa%2008%20de%20set%202014%20-%20Recomenda%C3%A7%C3%b5es%20Controle%20Contatos.pdfAccessed November 25, 2014
   Google Scholar
• ans.gov.br [homepage on the internet]Resolução Normativa – RN Nº 262, de 1 de agosto de 2011. Rol de Procedimentos; 2012: Fototerapia com PUVA Available from: http://www.ans.gov.br/images/stories/noticias/pdf/rn%20262.pdfAccessed November 25, 2014
   Google Scholar
• Campos NetoOHAcurcio FdeAMachadoMADoctors, lawyers and pharmaceutical industry on health lawsuits in Minas Gerais, Southeastern BrazilRev Saude Publica201246578479023128254
   PubMed Web of Science ®Google Scholar
• MachadoMAAcurcio FdeABrandãoCMJudicialization of access to medicines in Minas Gerais state, Southeastern BrazilRev Saúde Pública201145359059821445458
   PubMed Web of Science ®Google Scholar
• DograSKaurIKumarBLeprosy and psoriasis: an enigmatic relationshipInt J Lepr Other Mycobact Dis200371434134414763885
   PubMedGoogle Scholar
• KumarBRaychaudhuriSPVossoughSFarberEMThe rare coexistence of leprosy and psoriasisInt J Dermatol19923185515541428444
   PubMed Web of Science ®Google Scholar
• TeixeiraFMVasconcelosLMRola CdeAAlmeidaTLPValençaJTJrNagao-DiasATSecondary leprosy infection in a patient with psoriasis during treatment with infliximabJ Clin Rheumatol201117526927121778902
   PubMed Web of Science ®Google Scholar
• LydakisCIoannidouDKoumpaIDevelopment of lepromatous leprosy following etanercept treatment for arthritisClin Rheumatol201231239539822170033
   PubMed Web of Science ®Google Scholar
• AntonioJRSoubhiaRMPaschoal VdelAAmaranteCFTravoloARBiological agents: investigation into leprosy and other infectious diseases before indicationAn Bras Dermatol2013886 Suppl 12325
   Web of Science ®Google Scholar
• FerreiraCPMartinsCJIssaPROliveiraRVCDa-CruzAMPsoriasis affects individuals of African descent and white Brazilians similarlyActas Dermosifiliogr2010101323023420398598
   PubMedGoogle Scholar
• DuarteICunhaJABedrikowRBLazzariniRWhat is the most common phototherapy prescription for psoriasis: NB-UVB or PUVA? Prescription behaviorAn Bras Dermatol200984324424819668937
   PubMed Web of Science ®Google Scholar
• NettoEMTakahashiDde Fátima Paim de OliveiraMPhase II randomized, placebo-controlled trial of M. Vaccae-derived protein (PVAC) for the treatment of psoriasisVaccine200624235056506316621200
   PubMed Web of Science ®Google Scholar
• ans.gov.br [homepage on the internet]Dados e indicadores do setor2014 Available from: http://www.ans.gov.br/perfil-do-setor/dados-e-indicadores-do-setorAccessed November 25, 2014
   Google Scholar
• BRASIL. Ministério da SaúdePortaria n.º 1.318 de 23 de julho de 2002. Define, para o grupo 36, medicamentos, da tabela descritiva do sistema de informações ambulatoriais do Sistema Único de Saúde – SIA/SUS, a forma e a redação estabelecidas no anexo desta portaria. Seção 1Diário Oficial da República Federativa do Brasil, Poder ExecutivoBrasília, DF2472002
   Google Scholar
• BRASIL. Ministério da SaúdePortaria nº 2.981 de 26 de novembro de 2009. Aprova o Componente Especializado da Assistência Farmacêutica. Seção 131Diário Oficial da República Federativa do Brasil, Poder ExecutivoBrasília, DF1Dez2009
   Google Scholar
• AcurcioFABrandãoCMRWarAAJrPerfil demográfico e epidemiológico dos usuários de medicamentos de alto custo no Sistema Único de Saúde [Epidemiological profile of high cost medicines users in the Brazilian Health System]Rev Bras Estud Popul2009262263282
   Google Scholar
• portal.saude.gov [homepage on the internet]Clinical protocol for the treatment of moderate to severe psoriasisPCDT2004 Available from: http://portal.saude.gov.br/portal/saude/profissional/visualizar_texto.cfm?Idtxt=28510Accessed November, 25, 2014
   Google Scholar
• bvsms.saude.gov.br [homepage on the internet]Portaria no 44, de 9 de setembro de 2013. Torna pública a decisão de incorporar o medicamento metotrexato injetável para o tratamento da psoríase no Sistema Único de Saúde – SUS2013 Available from: http://bvsms.saude.gov.br/bvs/saudelegis/sctie/2013/prt0044_09_09_2013.htmlAccessed November 25, 2014
   Google Scholar
• SchmittJWozelGThe psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasisDermatology200521019419915785046
   PubMed Web of Science ®Google Scholar
• GarciaMMCusto da doença e perfil dos pacientes com psoríase moderada a grave atendidos no Hospital de Clínicas da Universidade Federal do Paraná. [Cost of Illness and Profile of Patients with Moderate to Severe Psoriasis Treated at the Hospital das Clinicas of the Federal University of Paraná] [dissertation]CuritibaUniversidade Federal do Paraná2013
   Google Scholar
• MoraisARibeiroRLimaRSuehiroRImpacto orçamentário do tratamento biológico da psoríase moderada a grave no SUS: uma ferramenta para tomadores de decisão [Budget impact analysis of biologic treatments of moderate to severe psoriasis in the Brazilian Public Healthcare System: a tool for decision-makers]J Bras Econ Saúde201031174180
   Google Scholar
• RaposoAASchettiniAPMSardinhaJCGPedrosaVLNosological profile in a dermatology referral center in the state of Amazonas – BrazilAn Bras Dermatol201186346346821738962
   PubMed Web of Science ®Google Scholar
• Sociedade Brasileira de DermatologiaPerfil nosológico das consultas dermatológicas no Brasil. [Nosologic profile of dermatologic visits in Brazil]An Bras Dermatol2006816549558
   Google Scholar
• BrunoMCVilelaMAOliveiraCAStudy on dermatoses and their prevalence in groups of confirmed alcoholic individuals in comparison to a non-alcoholic group of individualsAn Bras Dermatol201388336837523793198
   PubMed Web of Science ®Google Scholar
• DuarteGVOliveira MdeFCardosoTMAssociation between obesity measured by different parameters and severity of psoriasisInt J Dermatol201352217718122998685
   PubMed Web of Science ®Google Scholar
• BaetaIGRBittencourtFVGontijoBGoulartEMAComorbidities and cardiovascular risk factors in patients with psoriasisAn Bras Dermatol201489573574425184912
   PubMed Web of Science ®Google Scholar
• ImafukuSNaitoRNakayamaJPossible association of hepatitis C virus infection with late-onset psoriasis: a hospital-based observational studyJ Dermatol2013401081381823961783
   PubMed Web of Science ®Google Scholar
• World Health OrganizationPsoriasisProceedings of the sixty-seventh world health assemblyMay 24, 2014Geneva, Switzerland Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R9-en.pdfAccessed November 25, 2014
   Google Scholar
• RiverosBSAgentes biológicos no tratamento da psoríase moderada a grave: uma avaliação farmacoeconômica [Biological Agents in the Treatment of Moderate to Severe Psoriasis: A Pharmacoeconomic Evaluation] [dissertation]CuritibaUniversidade Federal do Paraná2014
   Google Scholar
• ChandranVRaychaudhuriSPGeoepidemiology and environmental factors of psoriasis and psoriatic arthritisJ Autoimmun2010343J314J32120034760
   PubMed Web of Science ®Google Scholar
• Magalhães da SilvaTSandhya RaniMRde Oliveira CostaGNThe correlation between ancestry and color in two cities of Northeast Brazil with contrasting ethnic compositionsEur J Hum Genet2014
   Web of Science ®Google Scholar
• ibge.gov.br [homepage on the internet]Atlas do Censo Demográfico 20102010 Available from: http://censo2010.ibge.gov.br/apps/atlas/Accessed November 25, 2014
   Google Scholar
• VasconcellosCDominguesPPAokiVMiyakeRKSauaiaNMartinsJEErythroderma: analysis of 247 casesRev Saude Publica19952931771828539528
   PubMed Web of Science ®Google Scholar
• SantosMFonsecaHMJalkhAPGomesGPCavalcanteASObesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in ManausAn Bras Dermatol201388691391624474099
   PubMed Web of Science ®Google Scholar
• FavaratoMHMeasePGonçalvesCRGonçalvesSCSampaio- BarrosPDGoldenstein-SchainbergCHypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritisClin Exp Rheumatol201432218218724480317
   PubMed Web of Science ®Google Scholar
• MenegonDBPereiraAGCamerinACCestariTPsoriasis and comorbidities in a southern Brazilian population: a case-control studyInt J Dermatol20145311518525
   Web of Science ®Google Scholar
• AndradeDLde Oliveira MdeFde SouzaTFA study about hepatitis C virus infection in patients with psoriasis in a Brazilian reference centerActa Gastroenterol Latinoam201242428529023383522
   PubMedGoogle Scholar
• DuarteGVda SilvaLPCorrelation between psoriasis’ severity and waist-to-height ratioAn Bras Dermatol201489584684725184937
   PubMed Web of Science ®Google Scholar
• RadtkeMAAugustinMEconomic considerations in psoriasis managementClin Dermatol200826542443118755360
   PubMed Web of Science ®Google Scholar
• NorlinJMSteen CarlssonKPerssonUSchmitt-EgenolfMResource use in patients with psoriasis after the introduction of biologics in SwedenActa Derm Venereol201595215616124819980
   PubMed Web of Science ®Google Scholar
• Le MoigneMSommetALapeyre-MestreMHealthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance databaseJ Eur Acad Dermatol Venereol20142891235124424236509
   PubMed Web of Science ®Google Scholar
• NastAMrowietzUKragballeKBarriers to the prescription of systemic therapies for moderate-to-severe psoriasis – a multinational cross-sectional studyArch Dermatol Res20133051089990723748949
   PubMed Web of Science ®Google Scholar
• BurmesterGRMeasePDijkmansBAAdalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesAnn Rheum Dis200968121863186919147611
   PubMed Web of Science ®Google Scholar
• GallowayJBHyrichKLMercerLKBSRBR Control Centre Consortium, British Society for Rheumatology Biologics RegisterAnti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyRheumatology (Oxford)201150112413120675706
   PubMed Web of Science ®Google Scholar
• BurmesterGRPanaccioneRGordonKBMcllraithMJLacerdaAPAdalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn’s diseaseAnn Rheum Dis201372451752422562972
   PubMed Web of Science ®Google Scholar
• PerezJKupperHSpencer-GreenGImpact of screening for latent TB before initiating anti-TNF therapy in North America and Europe [abstract]Ann Rheum Dis2005364 Suppl265
   Google Scholar
• LiuYGongJPLiWFTherapeutic effect and safety of ustekinumab for plaque psoriasis: a meta-analysisChin Med Sci J201429313113825264879
   PubMedGoogle Scholar
• SauratJHLangleyRGReichKUnnebrinkKSassoEHKampmanWRelationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION studyBr J Dermatol2011165239940621564071
   PubMed Web of Science ®Google Scholar
• SinghJAWellsGAChristensenRAdverse effects of biologics: a network meta-analysis and cochrane overviewCochrane Database Syst Rev2011162CD008794
   Google Scholar
• LeeSColemanCILimoneBBiologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque PsoriasisRockville, MDAgency for Healthcare Research and Quality (US)2012
   Google Scholar
• LangleyRGLebwohlMKruegerGGThe PHOENIX 2 InvestigatorsLong-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upBr J Dermatol Epub2014
   Google Scholar